Role of Inflammation and Its Treatment in ESRD Patients

Publisher： Karger

E-ISSN： 1421-9735|20|1|70-80

ISSN： 0253-5068

Source： Blood Purification, Vol.20, Iss.1, 2002-01, pp. : 70-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphism in Methylenetetrahydrofolate Reductase Gene: Its Impact on Plasma Homocysteine Levels and Carotid Atherosclerosis in ESRD Patients Receiving Hemodialysis

By  

Nephron, Vol. 87, Iss. 3, 2001-03 ,pp. : 249-256

Karger

Access to resources Recommend Favorite

Conveying Uncertainty in Prognosis to Patients with ESRD

By  

Blood Purification, Vol. 39, Iss. 1-3, 2015-01 ,pp. : 58-64

Karger

Access to resources Recommend Favorite

PD and the Future: The Role of PD in the Overall Management of ESRD

By  

Blood Purification, Vol. 21, Iss. 1, 2003-01 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

Impaired NK Cell Function in ESRD Patients

By  

Blood Purification, Vol. 26, Iss. 4, 2008-05 ,pp. : 315-316

Karger

Access to resources Recommend Favorite

Should the Hematocrit Be Normalized in Dialysis and in Pre-ESRD Patients?

By  

Blood Purification, Vol. 19, Iss. 2, 2000-12 ,pp. : 157-167

Karger

Access to resources Recommend Favorite